The D2 dopamine receptor (DRD2) gene is associated with co-morbid depression, anxiety and social dysfunction in untreated veterans with post-traumatic stress disorder - 01/01/05
, Burnett Kann, M.D. e, Terry Ritchie, Ph.D. bBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 6 |
| Iconographies | 1 |
| Vidéos | 0 |
| Autres | 0 |
Supported by The Greenslopes Private Hospital Research Foundation, Australia, Queensland University of Technology, Australia and the Adele C. Smithers-Fornaci and Christopher D. Smithers Foundation, United States
Abstract |
Objective. - To identify clusters of patients with post-traumatic stress disorder (PTSD) according to symptom profile and to examine the association of the A1 allele of the D2 dopamine receptor (DRD2) gene with these clusters.
Method. - Fifty-seven untreated Caucasian Vietnam veterans with PTSD were administered the General Health Questionnaire-28 (GHQ) and the Mississippi Scale for combat-related PTSD. DRD2 allelic status was determined by PCR.
Results. - Subjects with the DRD2 Al allele compared to those without this allele had significantly higher scores on GHQ 2 (anxiety/insomnia), GHQ 3 (social dysfunction) and GHQ 4 (depression). Cluster analysis of the GHQ data identified two primary groups. A high psychopathology cluster (cluster 3), featured by high co-morbid levels of somatic concerns, anxiety/insomnia, social dysfunction and depression, and a low psychopathology cluster (cluster 1), manifested by the reverse pattern. Scores in each of the four GHQ groups were significantly higher in cluster 3 than cluster 1, as was Mississippi Scale PTSD score. DRD2 A1 allele veterans compared to those without this allele were significantly more likely to be found in the high than the low psychopathology cluster group.
Conclusions. - DRD2 variants are associated with severe co-morbid psychopathology in PTSD subjects.
Le texte complet de cet article est disponible en PDF.Keywords : PTSD, DRD2 polymorphism, Anxiety, Depression, Social dysfunction
Plan
Vol 21 - N° 3
P. 180-185 - avril 2006 Retour au numéro
Article précédent
- A comparative study of fluoxetine, moclobemide, and tianeptine in the treatment of posttraumatic stress disorder following an earthquake
- E. Önder, Ü. Tural, T. Aker
- Psychiatric side effects of interferon-β in multiple sclerosis
- J.-L. Goeb, C. Even, G. Nicolas, B. Gohier, F. Dubas, J.B. Garré
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?